Until now, it is not yet known whether the level of XRCC2 expression can affect the sensitivity of radiotherapy for colon cancer and whether XRCC2 can predict the efficacy of colon cancer radiotherapy. This evidence concerns the gene XRCC2 and malignant colon neoplasm.